In the previously mentioned study, Sortilin was one member of the biomarker panel that showed effectiveness in improving the pathological diagnosis of PCa—especially in the differentiation of benign and malignant lesions—by labeling only well-formed malignant glands with specific supranuclear polar patterns [185]. Here, SORT1 is linked to posterior cortical atrophy.